CLTR COULTER PHARMACEUTICAL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (105)	8/15/1998 4:43:00 PM
From: shero	Read Replies (1) of 666

TNT data from the glioma trial should be out by years end. If I didn't already own TCLN I'd wait for the facts. As for bad financing deals the past is the past. There is about 17MM left in an equity line available, this was previously announced. No need to take down the money until it is needed, if the stock goes up alittle the terms are better. If LYM-1 is licensed soon that will bring in some non-dilutive funding. If this deal isn't complete by Aug.31 (if memeory serve me correctly) Legere gets the rights, so something may happen soon. Sorry to trespass, responsible comments and critisism will always be appreciated. Feel free to post on TCLN thread.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next